M&T Bank Corp acquired a new stake in Perrigo Company plc (NYSE:PRGO - Free Report) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 9,346 shares of the company's stock, valued at approximately $240,000.
Other large investors have also made changes to their positions in the company. Versant Capital Management Inc acquired a new stake in Perrigo in the 4th quarter valued at about $45,000. GAMMA Investing LLC raised its holdings in shares of Perrigo by 93.7% during the 4th quarter. GAMMA Investing LLC now owns 1,920 shares of the company's stock worth $49,000 after acquiring an additional 929 shares during the period. Central Pacific Bank Trust Division boosted its position in shares of Perrigo by 33.3% during the 4th quarter. Central Pacific Bank Trust Division now owns 2,000 shares of the company's stock valued at $51,000 after acquiring an additional 500 shares during the last quarter. Venturi Wealth Management LLC purchased a new stake in shares of Perrigo in the third quarter valued at about $56,000. Finally, KBC Group NV increased its position in Perrigo by 25.1% during the third quarter. KBC Group NV now owns 4,517 shares of the company's stock worth $118,000 after purchasing an additional 905 shares during the last quarter. 95.91% of the stock is owned by institutional investors and hedge funds.
Perrigo Trading Down 0.0 %
Shares of NYSE:PRGO traded down $0.01 during mid-day trading on Wednesday, reaching $27.86. 824,996 shares of the company were exchanged, compared to its average volume of 1,432,806. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The firm's 50-day simple moving average is $25.53 and its 200 day simple moving average is $26.16. Perrigo Company plc has a 1 year low of $23.14 and a 1 year high of $33.46. The firm has a market cap of $3.80 billion, a price-to-earnings ratio of -23.81 and a beta of 0.48.
Perrigo (NYSE:PRGO - Get Free Report) last posted its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The firm had revenue of $1.14 billion for the quarter, compared to the consensus estimate of $1.20 billion. Equities research analysts forecast that Perrigo Company plc will post 2.56 EPS for the current year.
Perrigo Increases Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be paid a $0.29 dividend. This is a positive change from Perrigo's previous quarterly dividend of $0.28. The ex-dividend date of this dividend is Friday, March 7th. This represents a $1.16 annualized dividend and a dividend yield of 4.16%. Perrigo's dividend payout ratio (DPR) is presently -92.80%.
Analyst Ratings Changes
Several equities analysts have weighed in on PRGO shares. Piper Sandler lowered shares of Perrigo from an "overweight" rating to a "neutral" rating and decreased their target price for the company from $34.00 to $27.00 in a report on Monday, January 6th. Argus cut Perrigo from a "buy" rating to a "hold" rating in a report on Tuesday, January 14th. Finally, StockNews.com lowered Perrigo from a "buy" rating to a "hold" rating in a research report on Wednesday, February 19th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the stock. According to MarketBeat.com, Perrigo presently has a consensus rating of "Hold" and an average price target of $33.00.
Check Out Our Latest Stock Analysis on PRGO
Insider Activity at Perrigo
In related news, EVP Ronald Craig Janish sold 7,800 shares of Perrigo stock in a transaction on Monday, March 10th. The stock was sold at an average price of $27.44, for a total value of $214,032.00. Following the completion of the transaction, the executive vice president now directly owns 33,666 shares in the company, valued at approximately $923,795.04. This trade represents a 18.81 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.70% of the company's stock.
About Perrigo
(
Free Report)
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Read More

Before you consider Perrigo, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Perrigo wasn't on the list.
While Perrigo currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.